No Data
Botao Biology (688767.SH): Plans to launch an employee stock ownership plan in 2024.
Galaxy Comprehensive News September 25th | Botuo Biotechnology (688767.SH) announced the 2024 employee stock ownership plan, the stocks in this employee stock ownership plan come from the company's repurchase special account to repurchase Botuo Biotechnology A ordinary shares. The target stocks to be held in this employee stock ownership plan will not exceed 2.15 million shares, accounting for approximately 2.02% of the total 106.666667 million shares of the company's capital stock on the date the draft of this employee stock ownership plan was announced. The funds for this employee stock ownership plan come from legitimate employee compensation, self-raised funds, and other methods allowed by laws and regulations. The company does not provide financial assistance or loans to shareholders.
Hangzhou Biotest BiotechLtd's (SHSE:688767) Shareholders May Want To Dig Deeper Than Statutory Profit
Summary of Botuo Biotech\'s 2024 Semi-Annual Report
Botuo Biotech 2024 Semi-Annual Report
Biotrack (688767.SH) released its semi-annual performance, with a net income of 72.18 million yuan, a year-on-year increase of 17.16%.
Biotech (688767.SH) disclosed its 2024 interim report, during the reporting period the company achieved revenue of 2.67...
Botao Biology (688767.SH): The net income in the first half of the year was 72.1751 million yuan, a year-on-year increase of 17.16%.
On August 29, Golonghui announced its semi-annual report for 2024, with operating revenue of 0.267 billion yuan, a year-on-year increase of 25.97%; net income attributable to shareholders of the listed company was 72.1751 million yuan, a year-on-year increase of 17.16%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 70.1048 million yuan, a year-on-year increase of 31.57%; basic earnings per share were 0.69 yuan.
No Data
No Data